Cardiovascular Diseases Clinical Trials in Montreal, Quebec
7 recruitingMontreal, Quebec, Canada
Showing 1–7 of 7 trials
Recruiting
Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1152 locationsNCT07064473
Recruiting
Phase 3
COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes
Cardiovascular DiseasesDiabete Type 2
Montreal Heart Institute10,000 enrolled39 locationsNCT05633810
Recruiting
Phase 3
Aggressive Smoking Cessation Trial (ASAP)
Cardiovascular DiseasesAcute Coronary Syndrome
Sir Mortimer B. Davis - Jewish General Hospital798 enrolled13 locationsNCT05257629
Recruiting
Translational-Omics in Aortic Stenosis (TOmAS) Biobank
Cardiovascular DiseasesAortic Valve Stenosis
McGill University Health Centre/Research Institute of the McGill University Health Centre10,000 enrolled2 locationsNCT05930899
Recruiting
Not Applicable
Clinical Utility of a Genomic Predictor Test on the Management of Cardiorenal Complications of Type 2 Diabetes
Cardiovascular DiseasesDiabetes Mellitus, Type 2Diabetic Nephropathy Type 2
Optithera2,714 enrolled2 locationsNCT06586203
Recruiting
Not Applicable
Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates
Cardiovascular DiseasesEnd Stage Renal DiseaseKidney Transplantation+1 more
University of British Columbia3,306 enrolled22 locationsNCT03674307
Recruiting
Not Applicable
Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"
Heart FailureCardiovascular Diseases
NHS Greater Glasgow and Clyde3,904 enrolled7 locationsNCT05919342